| Literature DB >> 28981291 |
Jie Liu1, Kang-Fei Hu1, Jian-Ping Qu2, Yan-Biao Kang1.
Abstract
In this work, an organopromoted metal-free pharmaceutical-oriented selectivity-switchable benzylic oxidation was developed, affording mono-, di-, and trioxygenation products, respectively, using oxygen as the oxidant under mild conditions. This process facilitates dioxygenation of 2,6-benzylic positions of heterocycles, which could be inhibited by heterocycle chelation to the metal cocatalysts. Enantiopure chiral ketones could also be prepared. The noninvolvement of transition metals and toxins avoids metal or hazardous residues, consequently ensuring a final-stage gram-scale synthesis of Lenperone.Entities:
Year: 2017 PMID: 28981291 DOI: 10.1021/acs.orglett.7b02731
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005